You may reduce what you pay for tirzepatide even without traditional insurance coverage. Eli Lilly offers both savings support and self-pay pathways for Zepbound® (their branded medication containing tirzepatide), which may lower monthly costs for eligible patients.
Access Without Insurance: Savings, Eligibility & Self-Pay Pricing
For patients with commercial plans that cover Zepbound®, the Zepbound® Savings Card may lower your out-of-pocket costs to as little as $25 per month. If your commercial plan doesn’t cover Zepbound®, you may be eligible to pay as low as $349 for a 1-month supply (program rules and limits apply). The Mounjaro® Savings Card offers similar benefits for eligible, commercially insured patients with Mounjaro® coverage.
Individuals with government-provided insurance (e.g., Medicare, Medicaid, VA, TRICARE) are not eligible for the Zepbound® Savings Card. If you fall into this category, Lilly’s Self Pay Journey Program through LillyDirect® provides an alternative. Transparent vial pricing currently lists $349 for the starter dose (2.5 mg) and $499 for the 5 mg dose, with 7.5 mg and 10 mg available for $499 when you refill within 45 days (otherwise, higher “regular” prices apply; higher doses, 12.5 mg and 15 mg, are also available under program terms).
If you’re paying cash, LillyDirect® single-dose vials may cost less than prefilled pen devices. For comparison, Zepbound® pens currently list at $1,086.37 per prescription fill before any discounts.
Telehealth Access & LillyDirect® Care Pathway
Telehealth platforms offer another option for accessing tirzepatide without insurance, by bundling provider oversight with medication for roughly $299-$600 per month. As mentioned, LillyDirect® is the manufacturer’s digital platform that connects patients with independent clinicians and offers direct pharmacy options for select Lilly medicines, including Zepbound®, with the self-pay vial pricing outlined above.
Where Eden Fits In
Eden coordinates your GLP-1 care from intake to follow-up with transparent, upfront pricing. Licensed providers evaluate whether tirzepatide is clinically appropriate and write prescriptions. Partner pharmacies dispense and label medications. We help you compare access paths (e.g., manufacturer savings, LillyDirect® self-pay vials, or pharmacy cash price).
